Antibody-Directed Enzyme Prodrug Therapy
- 1 November 1994
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 27 (5), 368-376
- https://doi.org/10.2165/00003088-199427050-00004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Tumour necrosis factor increases tumour uptake of Co-administered antibody-carboxypeptidase G2 conjugateEuropean Journal Of Cancer, 1993
- Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2Journal of Immunological Methods, 1993
- Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphateCancer Immunology, Immunotherapy, 1992
- Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsEuropean Journal of Cancer and Clinical Oncology, 1991
- Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugateBiochemical Pharmacology, 1991
- Improved Tumor Targeting With Radiolabeled, Recombinant, Single-Chain, Antigen-Binding ProteinJNCI Journal of the National Cancer Institute, 1990
- Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamideCancer Immunology, Immunotherapy, 1990
- Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2Journal of Medicinal Chemistry, 1990
- Carboxypeptidase-mediated release of methotrexate from methotrexate .alpha.-peptidesBiochemistry, 1989
- MONOCLONAL ANTIBODIES IN CANCER TREATMENTThe Lancet, 1986